Annual CFF
$8.98 M
+$5.19 M+137.16%
December 1, 2023
Summary
- As of February 8, 2025, IRD annual cash flow from financing activities is $8.98 million, with the most recent change of +$5.19 million (+137.16%) on December 1, 2023.
- During the last 3 years, IRD annual CFF has fallen by -$12.14 million (-57.49%).
- IRD annual CFF is now -67.47% below its all-time high of $27.61 million, reached on December 1, 2021.
Performance
IRD Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$353.00 K
-$1.19 M-77.08%
September 1, 2024
Summary
- As of February 8, 2025, IRD quarterly cash flow from financing activities is $353.00 thousand, with the most recent change of -$1.19 million (-77.08%) on September 1, 2024.
- Over the past year, IRD quarterly CFF has dropped by -$2.02 million (-85.14%).
- IRD quarterly CFF is now -98.19% below its all-time high of $19.50 million, reached on December 1, 2020.
Performance
IRD Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$7.87 M
-$5.02 M-38.95%
September 1, 2024
Summary
- As of February 8, 2025, IRD TTM cash flow from financing activities is $7.87 million, with the most recent change of -$5.02 million (-38.95%) on September 1, 2024.
- Over the past year, IRD TTM CFF has dropped by -$3.48 million (-30.67%).
- IRD TTM CFF is now -79.85% below its all-time high of $39.07 million, reached on September 1, 2021.
Performance
IRD TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
IRD Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +137.2% | -85.1% | -30.7% |
| 3 y3 years | -57.5% | -95.6% | -71.5% |
| 5 y5 years | +90.9% | -95.6% | -71.5% |
IRD Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -67.5% | +137.2% | -95.6% | +3041.7% | -72.4% | +498.2% |
| 5 y | 5-year | -67.5% | +137.2% | -98.2% | +3041.7% | -79.8% | +1657.1% |
| alltime | all time | -67.5% | +137.2% | -98.2% | +3041.7% | -79.8% | +1657.1% |
Opus Genetics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $353.00 K(-77.1%) | $7.87 M(-39.0%) |
| Jun 2024 | - | $1.54 M(-35.2%) | $12.89 M(+13.6%) |
| Mar 2024 | - | $2.38 M(-34.1%) | $11.36 M(+26.5%) |
| Dec 2023 | $8.98 M(+137.2%) | $3.60 M(-33.0%) | $8.98 M(+67.4%) |
| Sep 2023 | - | $5.38 M(>+9900.0%) | $5.36 M(+307.6%) |
| Jun 2023 | - | $0.00(0.0%) | $1.32 M(-54.7%) |
| Mar 2023 | - | $0.00(-100.0%) | $2.90 M(-23.3%) |
| Dec 2022 | $3.79 M | -$12.00 K(-100.9%) | $3.79 M(-68.0%) |
| Sep 2022 | - | $1.33 M(-16.4%) | $11.83 M(-2.2%) |
| Jun 2022 | - | $1.59 M(+80.0%) | $12.10 M(-57.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $882.00 K(-89.0%) | $28.48 M(+3.2%) |
| Dec 2021 | $27.61 M(+30.7%) | $8.03 M(+401.9%) | $27.61 M(-29.3%) |
| Sep 2021 | - | $1.60 M(-91.1%) | $39.07 M(+1.8%) |
| Jun 2021 | - | $17.96 M(>+9900.0%) | $38.40 M(+85.6%) |
| Mar 2021 | - | $10.00 K(-99.9%) | $20.68 M(-2.1%) |
| Dec 2020 | $21.12 M(+349.0%) | $19.50 M(+2010.0%) | $21.12 M(+1200.5%) |
| Sep 2020 | - | $924.00 K(+266.7%) | $1.62 M(+132.0%) |
| Jun 2020 | - | $252.00 K(-43.8%) | $700.00 K(+56.3%) |
| Mar 2020 | - | $448.00 K | $448.00 K |
| Dec 2019 | $4.70 M | - | - |
FAQ
- What is Opus Genetics annual cash flow from financing activities?
- What is the all time high annual CFF for Opus Genetics?
- What is Opus Genetics annual CFF year-on-year change?
- What is Opus Genetics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Opus Genetics?
- What is Opus Genetics quarterly CFF year-on-year change?
- What is Opus Genetics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Opus Genetics?
- What is Opus Genetics TTM CFF year-on-year change?
What is Opus Genetics annual cash flow from financing activities?
The current annual CFF of IRD is $8.98 M
What is the all time high annual CFF for Opus Genetics?
Opus Genetics all-time high annual cash flow from financing activities is $27.61 M
What is Opus Genetics annual CFF year-on-year change?
Over the past year, IRD annual cash flow from financing activities has changed by +$5.19 M (+137.16%)
What is Opus Genetics quarterly cash flow from financing activities?
The current quarterly CFF of IRD is $353.00 K
What is the all time high quarterly CFF for Opus Genetics?
Opus Genetics all-time high quarterly cash flow from financing activities is $19.50 M
What is Opus Genetics quarterly CFF year-on-year change?
Over the past year, IRD quarterly cash flow from financing activities has changed by -$2.02 M (-85.14%)
What is Opus Genetics TTM cash flow from financing activities?
The current TTM CFF of IRD is $7.87 M
What is the all time high TTM CFF for Opus Genetics?
Opus Genetics all-time high TTM cash flow from financing activities is $39.07 M
What is Opus Genetics TTM CFF year-on-year change?
Over the past year, IRD TTM cash flow from financing activities has changed by -$3.48 M (-30.67%)